pentoxifylline has been researched along with Hepatitis, Animal in 1 studies
Hepatitis, Animal: INFLAMMATION of the LIVER in non-human animals.
Excerpt | Relevance | Reference |
---|---|---|
"Pretreatment with pentoxifylline significantly reduced serum levels of liver enzymes (3800+/-650 vs 150+/-28 IU/l) and tumor necrosis factor alpha (710+/-105 vs 113+/-15 pg/ml) with no evidence of inflammation in histopathologic examination compared to control mice treated with concanavalin A." | 1.30 | Pentoxifylline prevents concanavalin A-induced hepatitis by reducing tumor necrosis factor alpha levels and inhibiting adhesion of T lymphocytes to extracellular matrix. ( Aeed, H; Avni, Y; Bruck, R; Frenkel, D; Halpern, Z; Hershkoviz, R; Kenet, G; Shirin, H; Zaidel, L, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shirin, H | 1 |
Bruck, R | 1 |
Aeed, H | 1 |
Frenkel, D | 1 |
Kenet, G | 1 |
Zaidel, L | 1 |
Avni, Y | 1 |
Halpern, Z | 1 |
Hershkoviz, R | 1 |
1 other study available for pentoxifylline and Hepatitis, Animal
Article | Year |
---|---|
Pentoxifylline prevents concanavalin A-induced hepatitis by reducing tumor necrosis factor alpha levels and inhibiting adhesion of T lymphocytes to extracellular matrix.
Topics: Animals; Cell Adhesion; Concanavalin A; Extracellular Matrix; Fibronectins; Hepatitis, Animal; Lactu | 1998 |